SERPINE1 and esophageal squamous cell carcinoma: PAI-1 in turn stimulates the survival of  AKT and MAPK pathways to protect ESCC from ROS-mediated DNA damage and cell death under chemotherapeutic drug treatment thus supporting resistance [245].